A note about this page: Prior to 2002, only some content was published online. Issues are presented as available, and may contain errors. If the article you require is not available, please contact us to purchase a reprint.
Editorials
- Facts and fables in management of Helicobacter pylori Gil O Barbezat (MJA 1999; 170: 348-349)
- Designer insulins: moving closer to convenient and physiological replacement of insulin Steven C Boyages (MJA 1999; 170: 349-350)
- Euthanasia consultants or facilitators? Herbert Hendin (MJA 1999; 170: 351-352)
- Healing the century of violence: towards sustainable peace Susan J Wareham, Ian Maddocks (MJA 1999; 170: 352-353)
Research
- Australian doctors' beliefs and practice regarding Helicobacter pylori Lindsay C Mollison, Konrad D Jamrozik, Aileen J Plant (MJA 1999; 170: 354-357)
- Consultants in cases of intended euthanasia or assisted suicide in the Netherlands Bregje D Onwuteaka-Philipsen, Gerrit van der Wal, Piet J Kostense, Paul J van der Maas (MJA 1999; 170: 360-363)
Healthcare
- Insulin lispro: experience in a private practice setting Alan E Stocks (MJA 1999; 170: 364-367)
Notable Cases
- Successful obstetric outcome after simultaneous pancreas and kidney transplantation Lukas K Kairaitis, Brian J Nankivell, Susan Lawrence, Michael C Nicholl, Philip J O'Connell, Kathy Kable, Jeremy R Chapman, Richard D M Allen (MJA 1999; 170: 368-370)
Viewpoint
- Risky business: health risk assessment and public health policy on environmental carcinogens Malcolm R Sim, John J McNeil (MJA 1999; 170: 372-374)
Position Statement
- Peter G Colman, David W Thomas, Paul Z Zimmet, Timothy A Welborn, Peter Garcia-Webb, M Peter Moore (MJA 1999; 170: 375-378)
New Drugs, Old Drugs
- Antiplatelet drugs Ross I Baker, Graeme J Hankey (MJA 1999; 170: 379-382)
MJA Practice Essentials -- Cardiology
- Cholesterol in perspective Brett H R Forge (MJA 1999; 170: 385-390)
Advertisement